This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech medical breakthrough

New CAMEO Sensor for Brain Organoids

Analysis based on 6 articles · First reported Apr 02, 2026 · Last updated Apr 03, 2026

Sentiment
70
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The development of CAMEO by North Carolina State University is expected to significantly reduce research costs for neurodevelopmental and genetic disorders, potentially accelerating drug discovery and therapeutic development. This breakthrough could lead to increased investment in biotechnology and medical device companies focused on neurological research tools.

Biotechnology Medical Devices Pharmaceuticals

Researchers at North Carolina State University, led by Navya Mishra, Amay Bandodkar, and Albert Keung, have developed a new low-cost, scalable sensor called CAMEO (Conformal Array for Monitoring Electrophysiology of Organoids). This device uses carbon nanotubes to monitor electrical activity in human cerebral organoids, which are millimeter-sized tissues used to study brain function and genetic disorders like Angelman syndrome. Current sensors are expensive, limiting studies to small sample sizes. CAMEO's affordability and ease of manufacturing will enable large-scale studies, providing more robust data for understanding neurodevelopment and developing treatments. The project received funding from the Foundation for Angelman Syndrome Therapeutics and the United States — National Science Foundation, and the intellectual property for CAMEO is being protected.

oth
Angelman syndrome is a genetic disorder that CAMEO is specifically designed to help researchers study, potentially leading to new therapeutic treatments.
Importance 85.0 Sentiment 60.0
per
Navya Mishra is the first author of the paper on CAMEO and a Ph.D. student at North Carolina State University, playing a key role in the sensor's development and advocating for its widespread adoption.
Importance 80.0 Sentiment 60.0
per
Amay Bandodkar is a co-corresponding author of the paper and an assistant professor at North Carolina State University, contributing to the development of CAMEO.
Importance 70.0 Sentiment 50.0
per
Albert Keung is a co-corresponding author of the paper and an associate professor at North Carolina State University, instrumental in developing CAMEO.
Importance 70.0 Sentiment 50.0
ngo
The Foundation for Angelman Syndrome Therapeutics provided funding for the development of CAMEO, supporting research into Angelman syndrome.
Importance 60.0 Sentiment 60.0
govactor
Importance 0.0 Sentiment 0.0
stock
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.